Study Comparing Three Doses of MDMA Along With Therapy in Veterans With Posttraumatic Stress Diso… (NCT01211405) | Clinical Trial Compass
CompletedPhase 2
Study Comparing Three Doses of MDMA Along With Therapy in Veterans With Posttraumatic Stress Disorder
United States26 participantsStarted 2010-11-10
Plain-language summary
The goal of this clinical trial is to learn if MDMA-assisted therapy is safe and effective and reducing PTSD symptoms in veterans with chronic PTSD. The main question it aims to answer is: Do three doses of MDMA reduce PTSD symptoms?
Researchers will compare 30, 75, and 125 mg of MDMA HCl with therapy to see which dose best reduces PTSD symptoms.
Participants will undergo three preparatory non-drug therapy sessions with a male and female co-therapist team, then undergo three day-long MDMA-assisted therapy sessions after receiving an initial dose of 30, 75, or 125 mg MDMA HCl. After each MDMA-assisted therapy session, participants will undergo three integrative therapy sessions.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Be diagnosed with chronic PTSD, duration of 6 months or longer resulting from traumatic experience during military service;
* Have a CAPS score showing moderate to severe PTSD symptoms;
* Have had at least one unsuccessful attempt at treatment for PTSD either with talk therapy or with drugs, or discontinuing treatment because of inability to tolerate psychotherapy or drug therapy.
* Are at least 18 years old;
* Must be generally healthy;
* Must sign a medical release for the investigators to communicate directly with their therapist and doctors;
* Are willing to refrain from taking any psychiatric medications during the study period;
* Willing to follow restrictions and guidelines concerning consumption of food, beverages, and nicotine the night before and just prior to each experimental session;
* Willing to remain overnight at the study site;
* Agree to have transportation other than driving themselves home or to where they are staying after the integrative session on the day after the MDMA session;
* Are willing to be contacted via telephone for all necessary telephone contacts;
* Must have a negative pregnancy test if able to bear children, and agree to use an effective form of birth control;
* Must provide a contact in the event of a participant becoming suicidal;
* Are proficient in speaking and reading English;
* Agree to have all clinic visit sessions recorded to audio and video
* Agree not to participate in any other interventional clinical tri…
What they're measuring
1
Change in Clinician-Administered PTSD Scale (CAPS-IV) From Baseline to Primary Endpoint
Timeframe: Baseline to one month after second experimental session